2007
DOI: 10.1001/archopht.125.7.994
|View full text |Cite
|
Sign up to set email alerts
|

Perioperative Management of Anticoagulated Patients Undergoing Repeated Intravitreal Injections

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2007
2007
2018
2018

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(1 citation statement)
references
References 5 publications
0
1
0
Order By: Relevance
“…In the MARINA trial of intravitreal ranibizumab, 60 patients on anticoagulation with warfarin received an average of 22 injections each, for a total of 1318 injections, with no significant bleeding complication documented. 14 Discontinuing a patient's warfarin or aspirin may increase the patient's risk of thromboembolic or cerebrovascular events, 15 and any decision to do so must be made in conjunction with the patient's primary care physician.…”
Section: Anticoagulationmentioning
confidence: 99%
“…In the MARINA trial of intravitreal ranibizumab, 60 patients on anticoagulation with warfarin received an average of 22 injections each, for a total of 1318 injections, with no significant bleeding complication documented. 14 Discontinuing a patient's warfarin or aspirin may increase the patient's risk of thromboembolic or cerebrovascular events, 15 and any decision to do so must be made in conjunction with the patient's primary care physician.…”
Section: Anticoagulationmentioning
confidence: 99%